Our findings also implicate the TNF pathway in CRCLM associated neutrophil populations, as well as LTB, complement system and antigen presentation pathways in CD4+ T cells from the same tissue, highlighting the potential of harnessing these aspects of the tumor microenvironment to selectively activate neutrophils for immunotherapy (7). This evidence concerns the gene CD4 and neoplasm.